<DOC>
	<DOCNO>NCT01137838</DOCNO>
	<brief_summary>To compare proportion rheumatoid arthritis ( RA ) patient prescribed opioids , benzodiazepine , antidepressant versus start follow biologics : abatacept , infliximab , etanercept , adalimumab , utilize administrative claim database .</brief_summary>
	<brief_title>Changes Use Opioids , Antidepressants , Benzodiazepines Rheumatoid Arthritis Patients Treated With Biologic Agents</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>ICD 9 diagnosis RA 714.0 Documented first biologic prescription ( `` index '' prescription ) abatacept , infliximab , etanercept , adalimumab Continuous therapy ( gap script great 150 % day supply ) minimum 6 month index Prescription claim data available 6 month 12 month index biologic prescription Continuous eligibility 6 month 12 month index biologic prescription Prescription claim another biologic observation period ( include rituximab anakinra ) Prescriptions continuous least 6 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>